Auto Amazon Links: No products found. Blocked by captcha.
Michelle Jones, a 36-year-old woman from Milford Haven, Pembrokeshire, who has Type 1 diabetes and is pregnant, has been offered an artificial pancreas to help regulate her insulin levels. The Hywel Dda health board introduced this new technology with the aim of transforming the experience of pregnant women with Type 1 diabetes. The system utilizes a glucose sensor to calculate and deliver precise insulin dosages required before and during pregnancy, allowing the diabetes team to monitor people’s glucose levels remotely, providing a sense of confidence and reassurance to patients like Michelle Jones.
This artificial pancreas consists of an insulin pump, glucose sensor, and an advanced algorithm running on an app. Mark Henwood, interim medical director at Hywel Dda, believes that this technology will make pregnancy safer and less stressful for women with Type 1 diabetes. Dr. Lisa Forrest, a consultant physician of diabetes and general medicine at Hywel Dda, highlights the importance of managing glucose levels for pregnant women with diabetes to reduce the risk of complications for newborns, such as premature birth, high birth weight, and need for intensive care.
Michelle Jones, who was diagnosed with Type 1 diabetes at the age of 19, found significant benefits from using the artificial pancreas during her pregnancy. Prior to using this technology, Michelle was using a diabetes pen but was switched to the artificial pancreas upon expressing her desire to become pregnant. The artificial pancreas allowed the diabetes team to closely monitor her blood sugar levels, resulting in significant improvements. The National roll-out of this technology began in October 2024 with the aim of offering it to all pregnant women with Type 1 diabetes by March 2027, as well as to any individual with Type 1 diabetes planning to conceive
Read the full article from The BBC here: Read More
Auto Amazon Links: No products found. Blocked by captcha.